The association of toxicities and outcomes with circulating endothelial cells (CEC) in non-small cell lung cancer (NSCLC) patients (pts) treated with bevacizumab (Bev).

被引：0
|
作者：
Sadraei, Nooshin Hashemi
Du, Lingling
Yadav, Ruchi
Grane, Ronald
Jacobs, Barbara
Hamulak, John
Ma, Patrick C.
Pennell, Nathan A.
Elson, Paul
Borden, Ernest C.
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Cleveland Clin, Cleveland, OH USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[5] Case Comprehens Canc Ctr, Cleveland, OH USA
[6] Cleveland Clin Fdn, Dept Translat Hematol & Oncol Res, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19012
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [2] Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel
    Kanda, Shintaro
    Yamada, Kazuhiko
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Sekine, Ikuo
    Kunitoh, Hideo
    Ohe, Yuichiro
    Watabe, Takeshi
    Shimoda, Yuji
    Tamura, Tomohide
    Koizumi, Fumiaki
    CANCER RESEARCH, 2009, 69
  • [3] Circulating Endothelial Cells in Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel
    Kawaishi, Makoto
    Fujiwara, Yutaka
    Fukui, Tomoya
    Kato, Terufumi
    Yamada, Kazuhiko
    Ohe, Yuichiro
    Kunitoh, Hideo
    Sekine, Ikuo
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Watabe, Takeshi
    Shimoda, Yuji
    Arao, Tokuzo
    Nishio, Kazuto
    Tamura, Tomohide
    Koizumi, Fumiaki
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 208 - 213
  • [4] Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel
    Kanda, Shintaro
    Yamada, Kazuhiko
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Sekine, Ikuo
    Kunitoh, Hideo
    Ohe, Yuichiro
    Watabe, Takeshi
    Shimoda, Yuji
    Tamura, Tomohide
    Koizumi, Fumiaki
    CANCER RESEARCH, 2009, 69
  • [5] PILOT STUDY TO MEASURE CIRCULATING ENDOTHELIAL CELLS (CECS) IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Pennell, Nathan
    Sadraei, Nooshin Hashemi
    Samsa, Julia
    Henderson, Lisa
    Grane, Ronald
    Borden, Ernest
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S970 - S971
  • [6] Circulating endothelial cells (CECs) in metastatic colorectal cancer (mCRC) patients (pts) treated with bevacizumab (BEV) and sorafenib.
    Lafky, J. M.
    Bot, B. M.
    Morlan, B. W.
    Anderson, S. K.
    Kimlinger, T. K.
    Halling, T. M.
    Kumar, S.
    Reynolds, J. T.
    Stella, P. J.
    Dakhil, S. R.
    Loui, W. S.
    Alberts, S. R.
    Grothey, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] VeriStrat predicts survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib and bevacizumab
    Salmon, J. S.
    Dang, T. P.
    Billheimer, D.
    Roder, H.
    Grigorieva, J.
    Tsypin, M.
    Herbst, R. S.
    Tsao, A. S.
    Tran, H.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] The association between PTEN expression and survival in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with erlotinib
    Hensing, T. A.
    Fidler, M. J.
    Wong, F.
    Polish, A.
    Watkin, W.
    Basu, S.
    Kaiser-Walters, K. A.
    Pool, M.
    Coon, J.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Differences in Circulating Angiogenic Biomarkers as Prognosticator for Outcome in Bevacizumab-Treated Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients
    Batus, M.
    Pithadia, R.
    Kubasiak, J.
    Fhied, C.
    Ibrahem, Z.
    Melinamani, S.
    Fughhi, I.
    Lie, W.
    Basu, S.
    Fidler, M.
    Bonomi, P. D.
    Borgia, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S75 - S75
  • [10] Association Between Endothelial Progenitor Cells and Treatment Response in Non-Squamous Non-small Cell Lung Cancer Treated with Bevacizumab
    Sudo, Kazuhisa
    Sato, Kazuhiro
    Sakamoto, Sho
    Hasegawa, Yukiyasu
    Asano, Mariko
    Okuda, Yuji
    Takeda, Masahide
    Sano, Masaaki
    Watanabe, Hiroyuki
    Shioya, Takanobu
    Ito, Hiroshi
    ANTICANCER RESEARCH, 2017, 37 (10) : 5565 - 5571
12345